Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS J9312 · per 10 MG

Inj., rituximab, 10 mg

Products billed under this code include Rituxan.

Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9312

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Rituxan Genentech, Inc. 50242-0051-21 10 $720.94
Rituxan Genentech, Inc. 50242-0053-06 50 $3,604.70

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $72.094 −$1.184 10 MG Inj., rituximab, 10 mg v1, posted September 17, 2026
3Q26 $73.278 −$0.88 10 MG Inj., rituximab, 10 mg v1, posted September 15, 2026
2Q26 $74.158 −$0.607 10 MG Inj., rituximab, 10 mg v1, posted September 15, 2026
1Q26 $74.765 −$0.455 10 MG Inj., rituximab, 10 mg v1, posted September 15, 2026
4Q25 $75.22 −$0.711 10 MG Inj., rituximab, 10 mg v1, posted September 8, 2026
3Q25 $75.931 −$0.502 10 MG Inj., rituximab, 10 mg v1, posted March 10, 2026
2Q25 $76.433 −$0.297 10 MG Inj., rituximab, 10 mg v1, posted March 10, 2026
1Q25 $76.73 −$0.584 10 MG Inj., rituximab, 10 mg v1, posted December 19, 2025
4Q24 $77.314 −$0.361 10 MG Inj., rituximab, 10 mg v1, posted June 11, 2025
3Q24 $77.675 −$1.197 10 MG Inj., rituximab, 10 mg v1, posted June 11, 2025
2Q24 $78.872 −$0.326 10 MG Inj., rituximab, 10 mg v1, posted March 11, 2025
1Q24 $79.198 −$0.994 10 MG Inj., rituximab, 10 mg v1, posted December 19, 2024
4Q23 $80.192 −$0.845 10 MG Inj., rituximab, 10 mg v1, posted October 10, 2024
3Q23 $81.037 −$0.15 10 MG Inj., rituximab, 10 mg v1, posted June 5, 2024
2Q23 $81.187 −$0.561 10 MG Inj., rituximab, 10 mg v1, posted February 23, 2024
1Q23 $81.748 −$0.503 10 MG Inj., rituximab, 10 mg v1, posted December 6, 2023
4Q22 $82.251 −$1.915 10 MG Inj., rituximab, 10 mg v1, posted June 22, 2023
3Q22 $84.166 −$1.269 10 MG Inj., rituximab, 10 mg v1, posted June 9, 2023
2Q22 $85.435 −$0.198 10 MG Inj., rituximab, 10 mg v1, posted December 14, 2022
1Q22 $85.633 −$1.304 10 MG Inj., rituximab, 10 mg v1, posted June 8, 2022
4Q21 $86.937 −$0.838 10 MG Inj., rituximab, 10 mg v1, posted June 2, 2022
3Q21 $87.775 −$1.366 10 MG Inj., rituximab, 10 mg v1, posted June 2, 2022
2Q21 $89.141 −$2.695 10 MG Inj., rituximab, 10 mg v1, posted March 1, 2022
1Q21 $91.836 – 10 MG Inj., rituximab, 10 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files